PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F05X4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $20,896
Award facts
- Contract value 100% obligated
- $20,895.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $20,895.86 to AmerisourceBergen Drug Corp on December 15, 2025, with completion expected by December 16, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems.
The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, PA. This delivery order exemplifies the company's established capability to fulfill federal medical supply requirements through competitive procurement, consistent with its extensive portfolio of contract awards with the DLA. AmerisourceBergen's prime IDC vehicle enables flexible pharmaceutical support across multiple therapeutic domains to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a key supplier within this strategic procurement framework.
Quick answers
Who was awarded contract SPE2D826F05X4?
SPE2D826F05X4 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 15, 2025.
How much is contract SPE2D826F05X4 worth?
The government has obligated $20,896 on SPE2D826F05X4.
Is contract SPE2D826F05X4 an order under another contract?
Yes. SPE2D826F05X4 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D826F05X4 competed?
The extent of competition for SPE2D826F05X4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award